FDA Calls for Immediate Removal of All Zantac, Ranitidine Products from the Market
The U.S. Food and Drug Administration (FDA) announced this week that it is asking manufacturers of Zantac and generic ranitidine products to withdraw all prescription and over-the-counter (OTC) versions of the drug from the market immediately. The FDA’s decision is the latest step in an ongoing investigation into the presence of a carcinogenic chemical called …
FDA Calls for Immediate Removal of All Zantac, Ranitidine Products from the Market Read More »